KFDA to approve clinical studies for 12 gene recombinant products.
The KFDA approved the clinical studies for 12 gene recombinant drugs including LB03002, a sustained type of human growth hormone developed by LG Life Science, Tifacogin inj. (Quintiles Korea), Remicade inj. 100mg (Infliximab mono clonal antibody by Schering Plough), Aropoetine free filled i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
